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The curly tail mouse provides a model for neural tube defects (spina biﬁda and exencephaly) that are
resistant to prevention by folic acid. The major ct gene, responsible for spina biﬁda, corresponds to a
hypomorphic allele of grainyhead-like 3 (Grhl3) but the frequency of NTDs is strongly inﬂuenced by
modiﬁers in the genetic background. Moreover, exencephaly in the curly tail strain is not prevented by
reinstatement of Grhl3 expression. In the current study we found that expression of Mthfd1L, encoding a
key component of mitochondrial folate one-carbon metabolism (FOCM), is signiﬁcantly reduced in ct/ct
embryos compared to a partially congenic wild-type strain. This expression change is not attributable to
regulation by Grhl3 or the genetic background at the Mthfd1L locus. Mitochondrial FOCM provides one-
carbon units as formate for FOCM reactions in the cytosol. We found that maternal supplementation with
formate prevented NTDs in curly tail embryos and also resulted in increased litter size. Analysis of the
folate proﬁle of neurulation-stage embryos showed that formate supplementation resulted in an
increased proportion of formyl-THF and THF but a reduction in proportion of 5-methyl THF. In contrast,
THF decreased and 5-methyl THF was relatively more abundant in the liver of supplemented dams than
in controls. In embryos cultured through the period of spinal neurulation, incorporation of labelled
thymidine and adenine into genomic DNA was suppressed by supplemental formate, suggesting that de
novo folate-dependent biosynthesis of nucleotides (thymidylate and purines) was enhanced. We
hypothesise that reduced Mthfd1L expression may contribute to susceptibility to NTDs in the curly tail
strain and that formate acts as a one-carbon donor to prevent NTDs.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The network of reactions that comprises folate one-carbon
metabolism (FOCM) supplies one carbon units for a number of
downstream biosynthetic pathways including nucleotide biosyn-
thesis and methylation reactions [1,2]. Corresponding with the
crucial role of FOCM in several cellular functions, abnormal FOCM is
associated with a range of diseases, including cancers, fatty liver
disease, inborn errors of metabolism, autism, age-related cognitiveentre, UCL Institute of Child
).
r B.V. This is an open access articleimpairment and birth defects, particularly neural tube defects
(NTDs). NTDs, including spina biﬁda and anencephaly, are a group
of birth defects that result from incomplete formation of the neural
tube which is the precursor of the brain and spinal cord in the
developing embryo [3]. The causes of most NTDs in humans are not
well understood owing to their complex etiology which is thought
to involve multiple genetic and environmental factors [4]. Sub-
optimal maternal folate status is associated with increased risk of
an NTD-affected pregnancy while maternal supplementation with
folic acid reduces susceptibility [5], although some NTDs are not
prevented (‘folic acid-resistant’). Polymorphisms and/or variants in
some FOCM-related genes (e.g. MTHFR, MTHFD1L, AMT and GLDC)
have been associated with NTDs [3,6], while abnormal thymidylateunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tients [7]. Together these data suggest that there is a contribution of
abnormal FOCM to NTDs, although it is currently unclear whether
this corresponds to NTDs that are preventable by or resistant to
folic acid.
Amongmousemodels of NTDs, some are responsive to folic acid,
including splotch (Sp2H, Pax3) and Cited2 null strains [8e10], while
others are resistant [11]. Among the latter group, the curly tail (ct)
strain has been studied extensively as a model for human NTDs
[12]. Homozygous ct/ct embryos develop partially penetrant NTDs
comprising spina biﬁda and/or exencephaly. These defects arise
due to failure in completion of neural tube closure in the spinal and
cranial regions respectively. Open NTDs only affect a proportion of
mutant embryos but even where neural tube closure is completed
around 50% of mice develop tail ﬂexion defects owing to delay in
spinal closure. The major ct gene corresponds to a hypomorphic
allele of Grhl3, encoding the grainyhead-like 3 transcription factor
[13,14]. However, penetrance of defects is strongly inﬂuenced by
genetic background [15]. For example, a polymorphic variant of
Lmnb1 was found to inﬂuence the frequency of both cranial and
spinal NTDs [16].
In addition to genetic modiﬁers, the frequency of NTDs in the ct
strain is inﬂuenced by several environmental factors, including
retinoic acid, inositol and hyperthermia [17e19]. However, there is
no protective effect of folic acid [12,20]. Supplemental folic acid
does not prevent NTDs in ct/ct embryos. However, they are sensitive
to maternal dietary folate deﬁciency, which causes a signiﬁcant
increase in the frequency of cranial NTDs and a delay in overall
growth and developmental progression, both in ct mice and in a
genetically matched wild-type strain (þct) [21]. The same dietary
model does not cause NTDs in other wild-type strains [21e23],
suggesting the presence of predisposing modiﬁer genes in the ct
genetic background. Analysis of cultured ﬁbroblasts did not indi-
cate a defect of thymidylate biosynthesis in the ct strain, but ab-
normalities of FOCM were observed [24]. For example, the SAM/
SAH ratio is lower in ct/ct than inþct/þct embryos at E10.5, owing to
increased abundance of SAH. Moreover, folate-deﬁciency led to an
increase rather than a decrease in SAM/SAH as observed in wild-
type and other strains. Diminished methylation appeared unlikely
to contribute to NTDs in ct/ct embryos as introduction of an Mthfr
null allele did not increase the frequency of NTDs; no NTDs were
observed among ct/ct;Mthfr/ embryos [24].
Although FA does not prevent NTDs in curly tail mice, we found
that intervening downstream of FOCM, at the level of nucleotide
biosynthesis may inﬂuence the rate of NTDs. Hence, combinations
of thymidine and adenine or GMP resulted in a signiﬁcant protec-
tive effect [25]. In the current study we further investigated the
potential contribution of altered FOCM to NTDs in the ct strain.
2. Materials and methods
2.1. Mice
Curly tail (Grhl3ct) and partially congenic wild-type strains (þct/
þct) were maintained as closed random-bred colonies [12,16].
Wild-typemice for plasma and urine analysis were on amixed CBA/
101 background. The transgenic curly tail line (Grhl3ct/Grhl3ct;
Tg(Grhl3)1Ndeg/0), here denoted ct/ctTgGrhl3/0, carries a BAC that
encompasses the Grhl3 gene, as described previously [13]. Mice
carrying a conditional (ﬂoxed) allele of Grhl3 have been described
[26]. These mice were crossed to b-actin-Cre mice to generate
heterozygous null, Grhl3þ/, mice used in experimental matings in
this study. Curly tail mice are maintained as a homozygous colony.
Other mice and embryos were genotyped by PCR of genomic DNA,
as described in the relevant original publications [13,26].Animal studies were carried out under regulations of the Ani-
mals (Scientiﬁc Procedures) Act 1986 of the UKGovernment, and in
accordance with guidance issued by the Medical Research Council,
UK in Responsibility in the Use of Animals for Medical Research (July
1993).2.2. Supplementation and collection of embryos
Experimental litters were generated by overnight mating. On
detection of a copulation plug the following morning, dams were
separated and litters designated embryonic day (E) 0.5. Treatments
were 20 mg/ml or 30 mg/ml sodium formate in drinking water and
control (water only). Doses were based on previous studies [27,28].
Formate treatment was started from E0.5 and continued until lit-
ters were collected, between E10.5 and 12.5. Embryos were
dissected from the uterus in Dulbecco's modiﬁed Eagle's medium
containing 10% foetal calf serum and assessed for the presence of
NTDs under a light microscope. Resorptions were recorded and the
crown-rump (CR) length measured using an eyepiece graticule.
Embryos were rinsed in PBS and stored at 80 C.2.3. Quantitative real time RT-PCR and sequencing
RNA was isolated using TRIzol (ambion) and DNA removed by
DNase ɪ digestion (DNA-Free, ambion). First strand cDNA synthesis
was performed using random hexamers (Superscript VILO cDNA
synthesis kit) and RT-qPCR was performed with iTaq
Universal SYBR Green Supermix (Bio-Rad) on a C1000 Touch
Thermal Cycler (Bio-Red). Primers for Mthfd1l were: 50-
TCATGGCCGTGCTGGCCTTG-30 and 50-TGGCAAAGGGACCAGCGTG-
30 and primers for Grhl3 were 50-CCAGACTCCAGTAACAATG-30 and
50-AAGGGTGAGCAGGTTCGCTT-30. Each sample was analysed in
triplicate and results were normalised to Gapdh mRNA abundance
as previously [13,16]. Similar results were obtained when Beta-actin
was used for normalisation.
The coding sequencing of Mthfd1L was sequenced in ct/ct
and þct/þct strains (2 independent embryos for each strain) using
cDNA prepared from E10.5 embryos (as above). A series of 8 over-
lapping primer pairs were used to amplify the entire coding region
(28 exons), as well as ﬂanking sequence (100 bp of the 50 UTR and
210 bp of the 30 UTR). PCR products were puriﬁed using QIAquick
PCR Puriﬁcation Kit (Qiagen). Products were sequenced in forward
and reverse directions by Sanger Sequencing (Source Bioscience)
and sequences were analysed using Sequencher (GeneCodes Cor-
poration) and compared to the reference Mthfd1L sequence (Gen-
Bank XM_006512449.2).2.4. Microsatellite and SNP genotyping
A series of 18 microsatellite markers (D10Mit84, D10Mit80,
D10Mit245, D10Mit123, D10Mit306, D10Mit279, RH125020,
RH126580, AI265638, 236300, AI317366, AW536662,
PMC25853P1), 236299, AU018232, D10Mit49 and 236303) and 4
SNPs (rs47265432, rs249746523, rs218957174, rs217495350)
ﬂanking and within Mthfd1L on mouse chromosome 10, were
tested for polymorphism between genomic DNA of SWR and curly
tail strains. Polymorphisms were detected either by size difference
between microsatellites or by sequencing of PCR products. A
synonymous coding SNP rs47265432 was informative. The
sequence at this SNP was determined by sequencing of a 432 bp
PCR product generated by primer pair 50-CTCCAGCACTGA-
GACCCTCT and 50-TGCTCCACCCTACCTGACTC.
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Folate proﬁle: Folates were quantiﬁed by ultra-pressure liquid
chromatography coupled to tandemmass spectrometry (UPLC-MS/
MS), as described previously [28,29]. Brieﬂy, E10.5 embryos were
resuspended in ‘folate buffer’ containing 20 mM ammonium ace-
tate, 0.1% ascorbic acid, 0.1% citric acid and 100mMdithiothreitol at
pH 7 and 0.2 mM methotrexate as internal standard. Samples were
sonicated using a hand-held sonicator for 10 s at 40% amplitude and
an aliquot removed for analysis of protein concentration using the
Bradford assay. Protein was precipitated using 2  volume of
acetonitrile and removed after centrifugation (12,000 g at 4 C).
Samples were then lyophilised and resuspended in 30 ml ‘folate
buffer’. Metabolites were resolved by reversed-phase UPLC (Acq-
uity UPLC BEH C18 column, Waters Corporation, UK) and detected
using a XEVO-TQS mass spectrometer (Waters Corporation) oper-
ating in negative-ion mode using the following settings: capillary
2.5 kV, source temperature 150 C, desolvation temperature 600 C,
cone gas ﬂow rate 150 l h1, and desolvation gas ﬂow rate
1200 l h1.
Formate: Blood was collected by terminal cardiac exsanguina-
tion into lithium-heparin tubes (BD Microtainer) and centrifuged
for the isolation of plasma. Blood and urine samples collected from
treated mice were taken after 12 days of formate treatment.
Formate concentration was determined by gas-phase chromatog-
raphy mass spectrometry, with urine concentration normalised to
creatinine as described previously [28,30].
2.6. Nucleotide incorporation
Incorporation of 3H nucleotide precursors into genomic DNA
was determined as described previously [25]. Embryos were
explanted at E9.5, leaving the yolk sac and ectoplacental cone intact
and cultured for 24 h in rat serum containing either [3H]-adenine
(2 mCi/ml), [3H]-thymidine or [3H]-CTP (both 1 mCi/ml), with 5 mM
sodium formate (formate treated) or an equivalent volume of
phosphate buffered saline (Control). Genomic DNA was isolated
and incorporation of 3H determined by scintillation counting as
described previously [25]. DNA concentration was measured by
Qubit™ (Thermo Fisher Scientiﬁc).
2.7. Western blot
The cranial region of embryos at E10.5 was suspended in RIPA
buffer and sonicated for 10 s using a hand-held sonicator at 40%
amplitude. An aliquot was taken for protein quantitation by Brad-
ford assay. 10 mg of protein was run per sample on NuPAGE 4e12%
Bis-Tris gel (Life technologies) and immunoblotted. Blocking was
performed overnight with BSA, followed by overnight incubation at
4 C with rabbit anti-Mthfd1l (1:1000; PA5-31360; Thermo Scien-
tiﬁc). After incubation with secondary antibody blots were devel-
oped using ECL Prime (GE Healthcare Life Sciences). Blots were
stripped and re-probed using mouse anti-Gapdh (1:20,000) and
ECL Western Blotting Substrate (Promega). Densitometry was per-
formed using Quantity One software (Bio-Rad).
2.8. Statistical analysis
Data are presented as mean ± SEM (n), unless otherwise indi-
cated. Statistics were conducted using GraphPad Prism (version
6.01; GraphPad Software Inc.) and SigmaStat (v3.5, Systat Soft-
ware). Supplementation data were analysed using Fisher's Exact
test. Means were compared using t-test or by one-way ANOVAwith
pairwise analysis by Holm-Sidak test as appropriate.3. Results
3.1. Diminished expression of Mthfd1L in curly tail embryos
Curly tail embryos are sensitive to maternal folate deﬁciency
and exhibit some FOCM alterations compared with wild-type [21].
We therefore asked whether curly tail embryos exhibited altered
expression of genes related to FOCM by interrogating a previously
reported microarray study [16], in which mRNA abundance in ct/ct
neurulation-stage embryoswas comparedwith a partially congenic
wild-type strain (þct/þct). Among a panel of 64 genes that encode
enzymes related to one-carbon metabolism [31], we noted signif-
icant alteration in expression of Mthfd1L (2-fold lower in ct/ct;
p < 0.05). Mthfd1L had previously been examined in the context of
neural tube closure: SNPs in MTHFD1L are associated with NTDs in
humans [32], while loss of function of Mthfd1L in mice results in
cranial NTDs [27]. In order to further investigate Mthfd1L expres-
sion in curly tail embryos we performed qRT-PCR. In samples
derived from the caudal region of embryos at E10.5, corresponding
to the tissue and stage at which spinal neurulation fails in curly tail
embryos,Mthfd1L expression was approximately 50% lower in ct/ct
embryos compared with stage-matched controls (Fig. 1A). Expres-
sion was similarly lower in the cranial region, analysed at E9.5
which is the stage when neural tube closure occurs at this axial
level (Fig. 1A). We further validated this ﬁnding by western blot
(Fig. 1B). Quantiﬁcation of band intensity showed a signiﬁcant
reduction in abundance of Mthfd1L protein in ct/ct embryos
compared with þct/þct (0.05 ± 0.01 vs 0.43 ± 0.09 arbitrary units,
normalised to Gapdh; p < 0.01, t-test).
3.2. Altered Mthfd1L expression in curly tail embryos does not
result from Grhl3 deﬁciency
The main genetic cause of NTDs in curly tail embryos is a
hypomorphic allele of Grhl3. We therefore tested whether Mthfd1L
may be a direct or indirect transcriptional target of Grhl3 by ana-
lysing expression in curly tail embryos carrying a Grhl3-BAC
transgene [13]. Expression of Grhl3 was increased in ct/ctTgGrhl3/
0 embryos but there was no apparent effect onMthfd1L expression,
either in the spinal region at E10.5 or in the cranial region at E9.5
(Fig. 1A). We also analysed Mthfd1L expression in Grhl3 null em-
bryos and found no difference from wild-type (Fig. 1C). These ob-
servations suggest that reduced Mthfd1L expression in ct/ct
embryos is not a result of Grhl3 deﬁciency. We next considered the
possibility that there is an effect of the ct genetic background on
Mthfd1L expression.
Thepartiallycongenicþct strain, used for transcriptomic analysis,
carries a region of SWR strain DNA at the Grhl3 locus (and is hence
designated wild-type for Grhl3). The remaining genetic background
is predicted to be 96% identical between ct/ct and þct/þct embryos,
with small regionsof SWRDNAremaining in theþct/þct strain (aswe
previously found on chromosome 18 [16]). We tested the possibility
that the variation in Mthfd1L expression between the two strains
results from retention of a region of SWR DNA encompassing the
Mthfd1L gene in the þct strain. Microsatellite markers and SNPs,
ﬂanking andwithinMthfd1L onmouse chromosome 10, were tested
for polymorphism between genomic DNA of SWR and curly tail
strains. A synonymous coding SNP, rs47265432, was informative;
this position is T in the SWR strain but C in ct and þct. A further
intronic SNP rs218957174, typedasT in ctandþctbutC inSWR.These
data indicate that Mthfd1L is not in a region where the genetic
background of the ct and þct strains differs. We also sequenced the
entire coding region of Mthfd1L ct/ct and þct/þct strains and
conﬁrmed that there is no difference in sequence between the
strains or variation from the reference sequence.
Fig. 1. Diminished expression of Mthfd1L in curly tail embryos. (A) Mthfd1L mRNA
abundance is signiﬁcantly lower in the caudal region of E10.5 (28e29 somite stage) ct/
ct embryos (n ¼ 6) and ct/ctTgGrhl3 (n ¼ 3) than in stage-matched þct/þct embryos
(n ¼ 3; p < 0.001, ANOVA). The cranial region of E9.5 ct/ct embryos also exhibits lower
abundance of Mthfd1L mRNA, which is not corrected in ct/ctTgGrhl3 embryos (n ¼ 2 per
group, p < 0.05). In contrast, Grhl3 expression is diminished in the E9.5 cranial region
of ct/ct embryos compared with þct/þct (p < 0.001; ANOVA), and is normalised by the
presence of a Grhl3-containing BAC (ct/ctTgGrhl3). (B) Immunoblots reveal a 104 kDa
band corresponding to Mthfd1L that is less abundant in ct/ct samples (caudal region at
E10.5) than stage-matched þct/þct samples. Immunoblot for Gapdh (37 kDa) is used as
loading control. (C) Analysis of a second group of E10.5 ct/ct (n ¼ 5) and þct/þct (n ¼ 3)
samples replicated the ﬁnding of reduced Mthfd1L expression in ct/ct (p < 0.01). In
contrast, no difference in Mthfd1L expression was detected between wild-type (n ¼ 6)
and Grhl3 null (n ¼ 7) embryos.
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Mthfd1L is required for production of formate from 10-formyl
THF in mitochondrial FOCM [1]. This is a crucial activity as
formate is transferred to the cytosol where it acts as a major one-
carbon donor in FOCM. The importance of mitochondrial FOCM in
neural tube closure is highlighted by the occurrence of NTDs in
mice carrying loss of function alleles of Mthfd1L, Gldc and Amt
[27,28,33]. We tested whether a deﬁcit of formate production could
contribute to curly tailNTDs by supplementing pregnant damswith
sodium formate in drinking water, as previously used in Mthfd1L
null mice [27]. Fetuses were scored according to the presence of
spina biﬁda, a tail ﬂexion defect (indicative of delayed spinal
neurulation) or a normal straight tail (Fig. 2). Spina biﬁda occurred
in 10e15% of embryos in the control groups. We observed a striking
dose-dependent effect on spinal NTDs, with a signiﬁcant reduction
in the frequency of spina biﬁda, which was present in only 2.9% (4/
136) of offspring of dams supplemented with 30 mg/ml (Fig. 2E).
The frequency of exencephaly (7.9% and 4.6% in the control groups)
also appeared lower in the groups treated with 20 mg/ml or 30 mg/
ml formate (2.2% and 1.5%) (Fig. 2F). Overall, exencephaly occurred
at signiﬁcantly lower frequency in formate-treated litters than in
control litters (p < 0.05).
We measured crown-rump length of embryos at E11.5 to test
whether formate supplementation had an effect on overall growth,
but no differences were observed (Table 1). Interestingly however,
the litter size among formate-supplemented damswas signiﬁcantly
larger than among contemporaneous control dams (Table 1).
3.4. Formate and folate analysis in supplemented dams and fetuses
Quantiﬁcation of formate by GC-MS conﬁrmed that oral sup-
plementation in drinking water led to a signiﬁcant elevation in
plasma formate in both ct and wild-type females (Table 2). The
plasma formate level appeared lower in curly tailmice than inwild-
type, both under normal and supplemented conditions, but this
was not statistically signiﬁcant (Table 2). Nevertheless, we analysed
formate in urine to ask whether excretion was higher in curly tail
females, potentially accounting for lower blood formate. Instead we
observed signiﬁcantly lower formate concentration in urine of
these mice (Table 2).
Formate produced by mitochondrial FOCM can enter cyto-
plasmic FOCM by acting as a one-carbon source for generation of
formyl-THF from tetrahydrofolate (THF), mediated by the formyl
synthetase activity of the trifunctional enzyme, Mthfd1 (Fig. 3A).
We tested whether maternal formate supplementation led to an
alteration in the relative proportions of cellular folates using an LC-
MS/MS method for quantiﬁcation of the mono- and poly-
glutamated (n1-7) forms of seven major folates [28,29]. In formate
supplemented ct/ct embryos we noted a reduction in the relative
proportion of 5-methyl-THF and an increase in the proportions of
THF and formyl-THF (CHO-THF), compared with non-
supplemented ct/ct controls (Fig. 3B). This was in striking contrast
to the liver of supplemented ct/ct dams which showed a signiﬁcant
increase in relative proportion 5-methyl-THF and a decrease in THF
(Fig. 3C).
3.5. Formate suppresses incorporation of exogenous nucleotides
into DNA
Formyl-THF provides one-carbon units for synthesis of purines
while 5,10-methylene-THF is a one-carbon donor for thymidylate
(dTMP) synthesis. Alternatively, nucleotide biosynthesis can be
mediated through salvage pathways that do not depend on FOCM.
For example, thymidine is converted to dTMP through the action of
Fig. 2. Formate prevents NTDs in curly tail mice. Among litters at E12.5 (AeD) we observed embryos with a straight tail (‘normal’, ST), tail ﬂexion defect (curly tail, CT), tail ﬂexion
defect with spina biﬁda (SB) and exencephaly (EX), which can occur in isolation or with a curly tail or spina biﬁda (scale bars represent 1 mm). (E) Among litters of dams sup-
plemented with formate in drinking water we observed a lower frequency of spina biﬁda (* indicates signiﬁcant difference from control group, p < 0.05; n ¼ 187 (0 mg/ml), 90
(20 mg/ml), 91 (0 mg/ml) and 138 (30 mg/ml) embryos). (F) The frequency of exencephaly was lower among all formate-treated litters than among all controls (p < 0.05) although
individual groups did not differ signiﬁcantly (n ¼ 109 (0 mg/ml), 90 (20 mg/ml), 91 (0 mg/ml) and 138 (30 mg/ml) embryos).
Table 1
Litter size and embryo size in formate-supplemented curly tail mice.
Formate conc. 0 mg/ml 20 mg/ml 0 mg/ml 30 mg/ml
No. Litters 15 10 13 14
Mean litter size 6.90 ± 0.50 9.00 ± 0.90* 7.00 ± 0.60 9.57 ± 0.40**
Mean crown-rump length (mm) (n) 7.78 ± 0.14 (25) 7.683 ± 0.04 (90) 7.88 ± 0.07 (47) 7.78 ± 0.03 (133)
Mean litter size of dams supplemented with 20 mg/ml or 30 mg/ml formate was larger than in control groups (*p < 0.05, **p < 0.01). The crown-rump length of embryos at
E12.5 did not differ among experimental groups.
Table 2
Formate concentration in plasma and urine ± formate supplementation.
Strain Plasma formate (mM) Urine formate (mM/mM creatinine)
Controls Formate-treatedy Control Formate-treatedyy
Curly tail (ct/ct) 36.5 ± 3.6 600.3 ± 144.4 15.5 ± 2.8* 438.6 ± 199.6
Wild-type (þ/þ) 50.7 ± 5.4 1267.0 ± 564.0 47.8 ± 2.9 1884.9 ± 873.5
Formate concentration in urine of female ct/ctmice was signiﬁcantly lower than in urine of wild-type mice (*p < 0.001). Amongmice supplemented with 30 mg/ml formate in
drinking water, the concentration of formate was signiﬁcantly higher in plasma (yp < 0.01) and in urine (yyp < 0.05) than in the equivalent non-supplemented controls
(n ¼ 3e4 mice in each group).
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action of APRT. Supplementation of ct/ct mice with a combination
of thymidine and adenine reduces the frequency of NTDs [25]. We
tested whether formate may be utilised in nucleotide biosynthesisby testing its effect on incorporation of exogenous thymidine or
adenine in cultured ct/ct embryos. Among embryos cultured in the
presence of formate we observed signiﬁcantly lower incorporation
of labelled thymidine or adenine (Fig. 4), supporting the hypothesis
Fig. 3. Folate proﬁle of formate-treated curly tail embryos and adult liver. (A) Outline
diagram of key reactions in FOCM, showing folates analysed. The relative proportions
of folates differs in (B) embryos (n ¼ 9 embryos per group) and (C) liver (n ¼ 3) of
formate-treated ct/ct dams compared with untreated ct/ct dams and dams. Data
represent the sum of all glutamated forms for each folate. Formate-treated embryos at
E10.5 exhibit a signiﬁcant increase in the relative amount of tetrahydrofolate (THF) and
formyl-THF (CHO-THF) and a decrease in the proportion of 5-methyl-THF (5mTHF)
(*p < 0.001, **p < 0.0001). In contrast, liver of treated adult mice exhibited a signiﬁcant
increase in proportion of 5mTHF and decrease in THF (*p < 0.05, **p < 0.01). The
proportion of dihydrofolate (DHF), methenyl-THF (CH ¼ THF) and methylene-THF
(CH2-THF) did not signiﬁcantly differ with treatment in either embryos or adult liver.
Fig. 4. Formate suppresses uptake of exogenous adenine and thymidine. Embryos
were cultured in the presence of labelled adenine, thymidine or CTP for 24 h from E9.5.
Incorporation of [3H]-adenine or thymidine into genomic DNA was signiﬁcantly lower
in the presence of additional formate (p < 0.01). Values are given as mean ± SEM;
n ¼ 4e6 embryos per group.
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AMP biosynthesis owing to enhanced use of the endogenous folate-
dependent synthetic reactions. Although formate did not affect
overall growth we considered the possibility that reduced incor-
poration of thymidine and adenine could result from decreased
DNA synthesis rather than suppression of the salvage pathways. In
a control experiment formate did not affect incorporation of
labelled CTP into DNA. This ﬁnding suggests that overall DNA
synthesis was not compromised and is consistent with the fact that
FOCM is not required for cytidine biosynthesis.4. Discussion
Spina biﬁda occurs in 10e15% of ct/ct embryos and can beprincipally attributed to reduced expression of Grhl3, being fully
rescued by transgenic Grhl3 expression [13]. In the current study
we also observed a signiﬁcant reduction in Mthfd1L expression in
ct/ct embryos at neurulation stages. Spinal NTDs have been re-
ported in only a very small proportion of Mthf1dL null mice [27].
Nevertheless we cannot rule out a potential contribution of
reducedMthfd1L expression to spina biﬁda in the ct strain, acting to
modify the Grhl3 effect, as we previously observed for a Lmnb1
variant (Deletion 18: 56909394) present in the ct genetic back-
ground. Cranial NTDs (exencephaly) also occur in Grhl3 null em-
bryos, but only among 2e14% unlike the 100% penetrance of spina
biﬁda [14,34]. In the current study we found that Grhl3 expression
is less abundant in the cranial region of ct/ct embryos than wild-
type and is normalised in the ct/ctTgGrhl3/0 embryos. However, un-
like spina biﬁda, cranial NTDs are not prevented in ct/ctTgGrhl3/
0 embryos, with exencephaly occurring among around 8% of em-
bryos (n ¼ 140), compared with 6e8% of ct/ct embryos (this study
and [16]). These ﬁndings suggest that cranial NTDs in ct/ct embryos
depend on genetic factors in addition to the hypomorphic Grhl3
allele. For example, exencephaly is reduced to 3% among a sub-
strain of ct/ct embryos with wild-type Lmnb1 but occurs at 2.6%
in a sub-strain of þct/þct embryos carrying the Lmnb1 Deletion 18:
56909394 variant [16]. Both the latter sub-strains exhibit dimin-
ished Mthfd1L expression similar to the ct/ct strain (data not
shown). We speculate that this could contribute to cranial NTDs, as
observed in Mthfd1L null embryos and other loss of function en-
zymes of mitochondrial FOCM (Gldc and Amt). In contrast, exen-
cephaly does not occur in the þct/þct strain (wild-type for Grhl3,
Lmnb1 and Mthfd1L expression) unless dietary folate deﬁciency is
imposed [21].
The protective effect of formate supplementation among ct/ct
embryos supports the hypothesis that there may be a deﬁciency in
supply of one-carbon units from mitochondrial FOCM, as would be
predicted in Mthfd1L hypomorphs. In addition to reduction in NTD
frequency inMthfd1L null embryos [27], formate also rescues NTDs
in mice with loss of function of Gldc (encoding glycine decarbox-
ylase) [28], another component of mitochondrial FOCM which acts
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proﬁles showed that the relative proportion of formyl-THF was
increased in supplemented ct/ct embryos similar to our previous
observations in wild-type or Gldc knockout embryos [28]. Inter-
estingly, the proportion of 5-methyl THF declined while that of THF
increased in formate-supplemented ct/ct embryos compared with
controls. This ﬁnding may at ﬁrst appear counter-intuitive. How-
ever, this alteration in folate proﬁle was consistent with our pre-
vious observation in wild-type embryos [28], whereas formate
caused an increase in proportion of 5-methyl-THF and formyl-THF
and a decrease in THF in Gldc null embryos. In contrast to em-
bryos, in adult liver the relative abundance of 5-methyl-THF was
increased by formate treatment while THF declined in abundance.
The variation in response to formate supplementation may reﬂect
the observed difference in the baseline folate proﬁles in these tis-
sues (5-methyl-THF makes up a greater proportion of total folates
in the embryo than in liver), which could result from differences in
metabolic requirements. In addition, the embryonic response may
include secondary effects of altered maternal metabolism com-
bined with increased formate levels.
We previously found that folate deﬁciency results in a signiﬁ-
cant reduction in implantations per litter and a signiﬁcant increase
in resorptions in the ct strain [21]. Although formate treatment did
not affect litter size in our previous study of Gldcmutant mice [28],
there was an apparent increase in litter size in both cohorts of
formate-treated ct mice in the current study. This appears unlikely
to result from improved survival of post-implantation embryos as
there was no difference in resorption rate in control and formate-
treated litters (data not shown). Moreover, supplementation was
not initiated until the day of ﬁnding a copulation plug so it is un-
likely that formate affected fertility per se. We speculate that
formate supplementation may have led to more successful im-
plantations or improved survival of pre-implantation embryos.
How does formate prevent NTDs in the ctmodel? Spinal NTDs in
ct/ct embryos are known to result from a proliferation defect in the
hindgut endoderm, which causes a growth imbalance in the caudal
region of the embryo undergoing neurulation [12]. Prevention of
NTDs by inositol or by a combination of nucleotides is associated
with stimulation of proliferation and normalisation of this growth
imbalance [25,35]. The increased abundance of formyl-THF
observed in formate-treated embryos would support supply of
one-carbon units for purine biosynthesis. Moreover, suppression of
the salvage pathways for dTMP and AMP by exogenous formate
supports the hypothesis that supplemental formate can provide
one-carbon donors for FOCM-mediated biosynthesis of both pu-
rines and thymidylate. This is also consistent with the previous
observation that supplementation with combinations of nucleo-
tides (thymidine þ adenine or thymidine þ GMP) can reduce the
frequency of NTDs in curly tail mice [25].
Having been found to prevent NTDs in mouse single gene mu-
tants for enzymes of mitochondrial FOCM [27,28], this study now
shows a protective effect of formate in an additional model, curly
tail, inwhich NTDs have a more complex genetic basis. The fact that
folic acid does not prevent NTDs in this model raises the question of
whether formate, or another one-carbon donor, may have thera-
peutic use in human NTDs. Production of formate has been pro-
posed as one potential mechanism underlying toxicity of excess
methanol in humans and primates [36]. Moreover, formate may
inhibit the respiratory chain [37]. We did not observe any delete-
rious effects of 5 mM sodium formate in cultured embryos,
although growth retarding and embryotoxic effects of sodium
formate have been reported in cultured mouse and rat embryos at
concentrations higher than 20 mM [38,39]. For comparison, in vivo
formate supplementation (30 mg/ml) of wild-type dams in the
current study produced plasma formate concentrations of around1.2 mM. Nevertheless, rodents may be less prone to formate accu-
mulation than humans owing to a greater capacity to remove
formate by oxidation [36]. Moreover, studies in sheep show higher
concentrations of formate in the foetal circulation and amniotic
ﬂuid compared to maternal plasma [40]. In adult female humans,
use of calcium formate at a signiﬁcantly higher dosage than present
in a typical supplement, led to plasma formate concentrations of
around 0.5 mM and this was cleared rapidly from the circulation
within 4 h [41]. This study was not however conducted during
pregnancy and additional safety evaluation would be necessary
before considering supplementation in pregnant women. Further
studies are justiﬁed to investigate the possible value of formate
supplements as part of a strategy for NTD prevention alongside folic
acid.
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